Business Wire
01 Apr 2026, 02:19 UTC · 30w ago
Verdict
Headline takes no side. We score CNTA +0.20 across two claims — slightly bullish.
+0.20slightly bullish
More positive than 52% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish
Eli Lilly and Company is proposing to acquire Centessa Pharmaceuticals plc for $38.00 per share in cash plus a contingent value right.
More positive than 99% of claims this week
The law firm Kahn Swick & Foti, LLC is investigating the proposed sale of Centessa Pharmaceuticals to Eli Lilly.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More negative than 71% of claims this week
Which stocks this story touches
More positive than 52% of ticker scores this week
The company is being acquired, though the mention of a legal investigation into the sale introduces slight uncertainty.
Near neutral — 91% of ticker scores this week are stronger
The company is acquiring another firm, which is a standard business expansion move with no clear sentiment expressed.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
MarketBeat
14h ago
+2.0%
Price agrees with the score
$40.50 vs $39.72 close before publication (Mar 31) · not market-adjusted
CNTA chart →
